TheraDoc, a clinical informatics company, has introduced a new patient safety surveillance tool to help hospitals address a recent Joint Commission National Patient Safety Goal focused on reducing the possibility of patient harm associated with anticoagulation therapy.
According to TheraDoc, the Anticoagulation Alerts package tracks the condition of patients receiving anticoagulation drug therapy to prevent blood clots, providing an early warning of potential adverse drug events or other problems.
The Anticoagulation Alerts package, designed for use with the TheraDoc Expert System Platform, was created in part based on the successful use of the many TheraDoc alerts at institutions such as the University of Pittsburgh Medical Center in the US. The package includes more than 30 alerts from existing TheraDoc products, and 13 new alerts are scheduled for release in the Anticoagulation Alerts package in May 2009.
TheraDoc’s patented expert system platform receives and standardizes patient data from multiple hospital information sources. With the platform as the ‘engine’, TheraDoc offers a suite of knowledge modules that includes the Infection Control Assistant, Antibiotic Assistant, ADE Assistant, and Clinical Alerts Assistant.
Michael Barton, senior vice president of knowledge and product development at TheraDoc, said: Our platform helps customers address a wide range of patient safety issues daily. The initial Anticoagulation Alerts package will be followed by a comprehensive anticoagulation service-the Anticoagulation Assistant module-which will be in beta testing by mid-year and available to customers by end of 2009.
Content from our partners
